End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Respiratory Products
100.0
%
| 331 | 100.0 % | 310 | 100.0 % | -6.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 331 | 100.0 % | 310 | 100.0 % | -6.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20-05-19 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 23-08-20 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 14-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-02-11 | |
Director/Board Member | 53 | 22-12-31 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 18-02-11 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 17-12-18 |
Mark Dipaolo
CHM | Chairman | 53 | 18-02-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,232,333 | 62,221,959 ( 65.34 %) | 32,005,000 ( 33.61 %) | 65.34 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ARMATA PHARMACEUTICALS, INC. 69.37% | 25,076,769 | 69.37% | 104,820,894 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- INVA Stock
- Stock
- Company Theravance Inc